Skip to main content

Table 3 Association of the three scores with treatment response of neoadjuvant chemotherapy for gastric cancer

From: CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer

CohortsModelsResponding groupNon-responding groupOR (95% CI)P value
Training cohortrad_score0.56 ± 0.260.38 ± 0.2514.51 (2.40, 98.35)< 0.01
clinical_score0.56 ± 0.110.47 ± 0.13355.62 (7.98, 2.41*104)< 0.01
rad_clinical score−0.61 ± 0.29−0.88 ± 0.3412.22 (2.79, 64.65)< 0.01
Validation cohortrad_score0.54 ± 0.120.42 ± 0.081.21*105 (52.25, 3.07*109)< 0.01
clinical_score0.52 ± 0.120.48 ± 0.1133.46 (0.07, 2.98*104)0.28
rad_clinical score−0.38 ± 0.23−0.56 ± 0.2716.90 (1.04, 422.82)0.06
  1. Abbreviations: OR odds ratio, CI confidence interval